SG Americas Securities LLC Makes New $276,000 Investment in Phibro Animal Health Co. (NASDAQ:PAHC)

SG Americas Securities LLC acquired a new position in Phibro Animal Health Co. (NASDAQ:PAHC) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 12,256 shares of the company’s stock, valued at approximately $276,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. CWM LLC lifted its holdings in Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after buying an additional 1,035 shares during the period. Fidelis Capital Partners LLC purchased a new stake in Phibro Animal Health in the first quarter worth about $46,000. Summit Securities Group LLC purchased a new stake in Phibro Animal Health in the second quarter worth about $83,000. Illinois Municipal Retirement Fund lifted its holdings in shares of Phibro Animal Health by 7.2% during the first quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after purchasing an additional 765 shares during the last quarter. Finally, Algert Global LLC purchased a new position in shares of Phibro Animal Health during the second quarter valued at approximately $193,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Performance

PAHC stock opened at $24.07 on Monday. The stock has a market capitalization of $974.91 million, a PE ratio of 75.22, a price-to-earnings-growth ratio of 0.60 and a beta of 0.52. Phibro Animal Health Co. has a 12-month low of $9.40 and a 12-month high of $25.11. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. The stock’s 50 day simple moving average is $21.13 and its 200 day simple moving average is $18.34.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.07. The business had revenue of $273.16 million for the quarter, compared to analysts’ expectations of $262.44 million. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. As a group, research analysts forecast that Phibro Animal Health Co. will post 1.55 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th were paid a dividend of $0.12 per share. The ex-dividend date was Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.99%. Phibro Animal Health’s dividend payout ratio is presently 150.00%.

Wall Street Analysts Forecast Growth

PAHC has been the subject of several recent research reports. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price for the company. Bank of America lifted their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Three research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus price target of $15.00.

Insider Buying and Selling at Phibro Animal Health

In related news, Director E Thomas Corcoran bought 5,000 shares of the firm’s stock in a transaction on Wednesday, September 4th. The stock was acquired at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the purchase, the director now owns 25,000 shares in the company, valued at approximately $500,500. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 50.06% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.